CN110804609A - Whole blood RNA rapid lysis solution and application - Google Patents

Whole blood RNA rapid lysis solution and application Download PDF

Info

Publication number
CN110804609A
CN110804609A CN201910932018.8A CN201910932018A CN110804609A CN 110804609 A CN110804609 A CN 110804609A CN 201910932018 A CN201910932018 A CN 201910932018A CN 110804609 A CN110804609 A CN 110804609A
Authority
CN
China
Prior art keywords
rna
purification column
nucleic acid
whole blood
000rpm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910932018.8A
Other languages
Chinese (zh)
Inventor
周志鹏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hangzhou Branch Biotechnology Ltd By Share Ltd
Original Assignee
Hangzhou Branch Biotechnology Ltd By Share Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Branch Biotechnology Ltd By Share Ltd filed Critical Hangzhou Branch Biotechnology Ltd By Share Ltd
Priority to CN201910932018.8A priority Critical patent/CN110804609A/en
Publication of CN110804609A publication Critical patent/CN110804609A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention provides a whole blood RNA rapid lysate and RNA extraction method without need of first cracking erythrocytes, the method greatly reduces the use of toxic reagents, simplifies the RNA extraction step, and the RNA obtained by purification has good integrity and high purity, and can be directly used for various molecular biology experiments such as RT-PCR, Northern blot, Dot blot and the like; the invention discloses a whole blood RNA rapid lysis solution, wherein each 1000ml of the lysis solution comprises the following components in parts by weight: guanidine thiocyanate, 0.2M-4M; ammonium thiocyanate, 0.2M-3M; anhydrous sodium acetate, 0.01M-0.2M; glacial acetic acid, 0.05-0.3M; 0.1-2% (W/V) of sodium lauroyl sarcosinate; sodium chloride, 0.02M-0.3M; 1% -15% (V/V) of glycerol; water saturated phenol solution, 10% -75% (V/V); the rest is DEPC treated water.

Description

Whole blood RNA rapid lysis solution and application
Technical Field
The invention relates to the technical field of blood RNA extraction, in particular to a whole blood RNA rapid lysate and application thereof.
Background
Blood is the most used in clinical aids because of its readily available nature. Blood tests are not only the primary basis for diagnosing various hematological disorders, but also provide a lot of important information for the diagnosis and identification of other systemic disorders. RNA extraction is a fundamental content in molecular biology research and is the basis for gene expression analysis. The rapid extraction of whole blood RNA saves researchers engaged in clinical research time, reduces the probability of RNA degradation, and can accelerate rapid diagnosis of certain diseases.
The main methods for extracting RNA from blood include precipitation, magnetic bead method and silica gel column method, depending on the type of RNA adsorption medium. The precipitation method is a method of subjecting RNA to centrifugal precipitation by utilizing the property that RNA is insoluble in ethanol and isopropanol. The method has the advantages of complicated operation steps, long time consumption, low flux and unstable quality of the obtained RNA. The basic principle of the magnetic bead method is the same as that of the silica gel column method, but the magnetic bead method enriches RNA on magnetic beads under the action of separating liquid salt and an external magnetic field, so that separation is realized. The silica gel column method is to enrich RNA on a solid phase silica gel column under the action of a separation liquid salt and realize separation through centrifugation.
The extraction method is classified into various methods such as Trizol method (phenol method), SDS method, CTAB method, guanidinium thiocyanate method, and the like, and a method using protease K in combination.
The Trizol method is good in universality and high in RNA extraction quality, and is commonly used for blood RNA extraction; however, chloroform used in the procedure is a toxic reagent, which is not good for the health of the laboratory operator. The method effectively avoids the toxic reagent, and the extraction effect is not inferior to that of the Trizol method. In other various cell lysis methods, red blood cells need to be lysed first, and then the white blood cells are obtained and then lysed. The lysis solution does not need to firstly lyse red blood cells, and can effectively shorten the RNA extraction time.
The basic principle of the current column method for extracting RNA is as follows: RNA is released from cells under the actions of sample pretreatment and lysate lysis; transferring the supernatant containing RNA to a nucleic acid purification column in a solution with high salt and low pH, and binding the RNA to the nucleic acid purification column after centrifugation; further removing impurities such as protein in the nucleic acid purification column membrane under the action of the washing solution 1; under the condition of washing liquid 2, further removing salt ions in the nucleic acid purification column membrane; finally, the RNA is eluted from the purification column under low salt conditions.
The invention provides the whole blood RNA rapid lysate and the RNA extraction method without cracking erythrocytes first, which simplify the experimental steps, shorten the whole RNA extraction time and greatly reduce the use of toxic reagents.
Disclosure of Invention
In order to achieve the purpose, the invention provides the following technical scheme: a whole blood RNA rapid lysis solution, each 1000ml volume of which is composed of the following components by mass/volume:
guanidine thiocyanate, 0.2M-4M;
ammonium thiocyanate, 0.2M-3M;
anhydrous sodium acetate, 0.01M-0.2M;
glacial acetic acid, 0.05-0.3M;
0.1-2% (W/V) of sodium lauroyl sarcosinate;
sodium chloride, 0.02M-0.3M;
1% -15% (V/V) of glycerol;
water saturated phenol solution, 10% -75% (V/V);
the rest is DEPC treated water.
The application of the whole blood RNA rapid lysate in the whole blood column method for extracting RNA;
the method comprises the following steps:
step one, whole blood lysis: adding 1ml of the rapid lysis solution into a 2ml centrifuge tube, adding 500 mu l of fresh whole blood or bone marrow, covering a tube cap, carrying out vortex oscillation for 30 seconds, and centrifuging at 13,000rpm for 10 minutes;
step two, passing the RNA-containing supernatant through a purification column: adding 400 mu l of absolute ethyl alcohol into a new 1.5ml centrifuge tube, sucking 700 mu l of the centrifugal supernatant obtained in the first step, transferring the centrifugal supernatant into the tube, and uniformly blowing and sucking the centrifugal supernatant by using a suction head; pipetting 600. mu.l of the mixture, transferring the mixture to a nucleic acid purification column, tightly covering the tube cap, and centrifuging at 13,000rpm for 1 minute; discarding the filtrate, placing the nucleic acid purification column back into a 2ml centrifuge tube, transferring the remaining mixture to the nucleic acid purification column, tightly covering the tube cap, and centrifuging at 13,000rpm for 1 minute;
step three, washing and deproteinizing: discarding the filtrate, putting the nucleic acid purification column back to a 2ml centrifuge tube, adding 500. mu.l of washing solution 1, tightly covering the tube cover, and centrifuging at 13,000rpm for 1 minute;
step four, washing and desalting: discarding the filtrate, putting the nucleic acid purification column back to a 2ml centrifuge tube, adding 700. mu.l of washing solution 2, tightly covering the tube cover, and centrifuging at 13,000rpm for 1 minute;
step five, eluting RNA: discarding the filtrate, putting the nucleic acid purification column back into a 2ml centrifuge tube, and centrifuging at 14,000rpm for 1 minute; discarding the filtrate and centrifuge tube, placing the nucleic acid purification column into a 1.5ml of centrifuge tube without RNase, adding 50 μ l of RNase-Free Water into the center of the membrane of the purification column, tightly covering the tube cover, standing at room temperature for 1 minute, and centrifuging at 12,000rpm for 30 seconds; the column was discarded and the eluted RNA was used immediately for molecular biology experiments or stored at-80 ℃ until use.
Preferably, the nucleic acid purification column is coated with SiO2Silica gel adsorption column of the material.
Preferably, the washing solution 1 is prepared from guanidine thiocyanate 0.5M-4M, Tris-HCl (pH6.0-pH8.0)10mM-100mM, EDTA-2Na (pH8.0)10mM-50mM and absolute ethyl alcohol 40% -60%.
Preferably, the washing solution 2 is 10mM-100mM of Tris-HCl (pH6.0-pH8.0), 20mM-300mM of sodium chloride, and 60% -80% of absolute ethyl alcohol.
Preferably, the RNase-Free Water is 0.1% DEPC treated Water.
The invention has the beneficial effects that: the rapid lysate of the invention does not need to separate the white blood cells in advance, greatly shortens the extraction time of the whole blood RNA, and has the characteristics of rapidness, conciseness and high efficiency; the RNA obtained by purification has good integrity and high purity, and can be directly used for various molecular biological experiments such as RT-PCR, Northern blot, Dot blot and the like.
The whole blood sample can be fresh whole blood or frozen whole blood at-80 ℃, the subsequent operation can be suspended after the whole blood is cracked, the cracked whole blood is directly frozen at-20 ℃ or-80 ℃, and the integrity and yield of RNA are not influenced when the experiment operation is subsequently carried out.
Drawings
In FIG. 1, left 1 and right 1 are graphs showing the delamination of human anticoagulated whole blood after the human anticoagulated whole blood is lysed with the lysis solution of example 1 and example 2, respectively, and centrifuged at 13,000rpm for 10 minutes.
FIG. 2 is an electrophoretic test image of RNA extraction from 4 portions of fresh human anticoagulated whole blood using the formulation of example 1 of the present invention; wherein lane M is DL 2,000 DNAmarker.
FIG. 3 is an electrophoretic image of RNA extraction from anticoagulated whole blood stored at-80 ℃ for one month using the method of example 3 of the present invention; wherein lane M is DL 2,000 DNAmarker.
FIG. 4 is an electrophoretic image of RNA obtained by performing rapid lysis of 3 portions of fresh anticoagulated whole blood, storing the supernatant at-20 ℃ for one week, and performing a subsequent extraction step, according to example 4 of the present invention.
Detailed Description
Example 1
A preparation method of a rapid whole blood RNA lysate, wherein each 1000ml of the lysate consists of the following components in mass/volume:
guanidine thiocyanate, 236.32g
Ammonium thiocyanate, 60.89g
Anhydrous sodium acetate, 4.102g
Glacial acetic acid, 14.25ml
Sodium lauroyl sarcosinate, 2.5g
Sodium chloride, 11.68g
Glycerol, 75ml
Aqueous saturated phenol solution, 500ml
The rest is DEPC treated water.
4 parts of 500. mu.l human anticoagulated whole blood are subjected to rapid lysis and RNA extraction, comprising the following steps:
step one, whole blood lysis: adding 1ml of the rapid lysis solution into a 2ml centrifuge tube, adding 500 mu l of fresh human anticoagulated whole blood, covering a tube cover, carrying out vortex oscillation for 30 seconds, and centrifuging at 13,000rpm for 10 minutes; taking a photograph of 4 parts with consistent layering conditions, as shown in the left 1 of the figure 1;
step two, passing the RNA-containing supernatant through a purification column: adding 400 mu l of absolute ethyl alcohol into a new 1.5ml centrifuge tube, sucking 700 mu l of the centrifugal supernatant obtained in the first step, transferring the centrifugal supernatant into the tube, and uniformly blowing and sucking the centrifugal supernatant by using a suction head; pipetting 600. mu.l of the mixture, transferring the mixture to a nucleic acid purification column, tightly covering the tube cap, and centrifuging at 13,000rpm for 1 minute; discarding the filtrate, placing the nucleic acid purification column back into a 2ml centrifuge tube, transferring the remaining mixture to the nucleic acid purification column, tightly covering the tube cap, and centrifuging at 13,000rpm for 1 minute;
step three, washing and deproteinizing: discarding the filtrate, putting the nucleic acid purification column back to a 2ml centrifuge tube, adding 500. mu.l of washing solution 1, tightly covering the tube cover, and centrifuging at 13,000rpm for 1 minute;
step four, washing and desalting: discarding the filtrate, putting the nucleic acid purification column back to a 2ml centrifuge tube, adding 700. mu.l of washing solution 2, tightly covering the tube cover, and centrifuging at 13,000rpm for 1 minute;
step five, eluting RNA: discarding the filtrate, putting the nucleic acid purification column back into a 2ml centrifuge tube, and centrifuging at 14,000rpm for 1 minute; discarding the filtrate and centrifuge tube, placing the nucleic acid purification column into a 1.5ml of centrifuge tube without RNase, adding 50 μ l of RNase-Free Water into the center of the membrane of the purification column, tightly covering the tube cover, standing at room temperature for 1 minute, and centrifuging at 12,000rpm for 30 seconds; the column was discarded and the eluted RNA was used immediately for molecular biology experiments or stored at-80 ℃ until use.
Table 1 shows OD values of RNA extracted from four whole blood samples according to the protocol of example 1, measured on a multifunctional microplate reader.
Figure BDA0002220482520000051
TABLE 1
Example 2
A preparation method of a whole blood RNA rapid lysate, wherein each 1000ml volume of the whole blood RNA rapid lysate comprises the following components by mass/volume:
guanidine thiocyanate, 118.16g
Ammonium thiocyanate, 30.45g
Anhydrous sodium acetate, 8.20g
Glacial acetic acid, 21.5ml
Sodium lauroyl sarcosinate, 5g
Sodium chloride, 5.84g
Glycerol, 50ml
Aqueous saturated phenol solution, 300ml
The rest is DEPC treated water.
1 part of 500. mu.l of human anticoagulated whole blood is subjected to rapid lysis and RNA extraction, comprising the following steps:
step one, whole blood lysis: adding 1ml of the rapid lysis solution into a 2ml centrifuge tube, adding 500 mu l of fresh human anticoagulated whole blood, covering a tube cover, carrying out vortex oscillation for 30 seconds, and centrifuging at 13,000rpm for 10 minutes; the layering situation is shown in fig. 1, right 1;
step two, passing the RNA-containing supernatant through a purification column: adding 400 mu l of absolute ethyl alcohol into a new 1.5ml centrifuge tube, sucking 700 mu l of the centrifugal supernatant obtained in the first step, transferring the centrifugal supernatant into the tube, and uniformly blowing and sucking the centrifugal supernatant by using a suction head; pipetting 600. mu.l of the mixture, transferring the mixture to a nucleic acid purification column, tightly covering the tube cap, and centrifuging at 13,000rpm for 1 minute; discarding the filtrate, placing the nucleic acid purification column back into a 2ml centrifuge tube, transferring the remaining mixture to the nucleic acid purification column, tightly covering the tube cap, and centrifuging at 13,000rpm for 1 minute;
step three, washing and deproteinizing: discarding the filtrate, putting the nucleic acid purification column back to a 2ml centrifuge tube, adding 500. mu.l of washing solution 1, tightly covering the tube cover, and centrifuging at 13,000rpm for 1 minute;
step four, washing and desalting: discarding the filtrate, putting the nucleic acid purification column back to a 2ml centrifuge tube, adding 700. mu.l of washing solution 2, tightly covering the tube cover, and centrifuging at 13,000rpm for 1 minute;
step five, eluting RNA: discarding the filtrate, putting the nucleic acid purification column back into a 2ml centrifuge tube, and centrifuging at 14,000rpm for 1 minute; discarding the filtrate and centrifuge tube, placing the nucleic acid purification column into a 1.5ml of centrifuge tube without RNase, adding 50 μ l of RNase-Free Water into the center of the membrane of the purification column, tightly covering the tube cover, standing at room temperature for 1 minute, and centrifuging at 12,000rpm for 30 seconds; the column was discarded and the eluted RNA was used immediately for molecular biology experiments or stored at-80 ℃ until use.
Example 3
A preparation method of a whole blood RNA rapid lysate, wherein each 1000ml volume of the whole blood RNA rapid lysate comprises the following components by mass/volume:
guanidine thiocyanate, 236.32g
Ammonium thiocyanate, 152.24g
Anhydrous sodium acetate, 2.75g
Glacial acetic acid, 9.5ml
Sodium lauroyl sarcosinate, 2.5g
Sodium chloride, 5.84g
Glycerol, 75ml
Aqueous saturated phenol solution, 500ml
The rest is DEPC treated water.
RNA extraction was performed on 3 parts of human anticoagulated whole blood stored at-80 ℃ for one month, comprising the following steps:
step one, whole blood lysis: adding 1ml of the rapid lysis solution into a 2ml centrifuge tube, adding 500 mu l of unfrozen human anticoagulated whole blood, covering a tube cover, carrying out vortex oscillation for 30 seconds, and centrifuging at 13,000rpm for 10 minutes;
step two, passing the RNA-containing supernatant through a purification column: adding 400 mu l of absolute ethyl alcohol into a new 1.5ml centrifuge tube, sucking 700 mu l of the centrifugal supernatant obtained in the first step, transferring the centrifugal supernatant into the tube, and uniformly blowing and sucking the centrifugal supernatant by using a suction head; pipetting 600. mu.l of the mixture, transferring the mixture to a nucleic acid purification column, tightly covering the tube cap, and centrifuging at 13,000rpm for 1 minute; discarding the filtrate, placing the nucleic acid purification column back into a 2ml centrifuge tube, transferring the remaining mixture to the nucleic acid purification column, tightly covering the tube cap, and centrifuging at 13,000rpm for 1 minute;
step three, washing and deproteinizing: discarding the filtrate, putting the nucleic acid purification column back to a 2ml centrifuge tube, adding 500. mu.l of washing solution 1, tightly covering the tube cover, and centrifuging at 13,000rpm for 1 minute;
step four, washing and desalting: discarding the filtrate, putting the nucleic acid purification column back to a 2ml centrifuge tube, adding 700. mu.l of washing solution 2, tightly covering the tube cover, and centrifuging at 13,000rpm for 1 minute;
step five, eluting RNA: discarding the filtrate, putting the nucleic acid purification column back into a 2ml centrifuge tube, and centrifuging at 14,000rpm for 1 minute; discarding the filtrate and centrifuge tube, placing the nucleic acid purification column into a 1.5ml of centrifuge tube without RNase, adding 50 μ l of RNase-Free Water into the center of the membrane of the purification column, tightly covering the tube cover, standing at room temperature for 1 minute, and centrifuging at 12,000rpm for 30 seconds; the column was discarded and the eluted RNA was used immediately for molecular biology experiments or stored at-80 ℃ until use.
Example 4
RNA extraction was performed on 3 parts of fresh human anticoagulated whole blood according to the lysate formulation of example 3, comprising the following steps:
step one, whole blood lysis: adding 1ml of the rapid lysis solution into a 2ml centrifuge tube, adding 500 mu l of unfrozen human anticoagulated whole blood, covering a tube cover, carrying out vortex oscillation for 30 seconds, and centrifuging at 13,000rpm for 10 minutes;
step two, transferring 700 mu l of supernatant into a new 1.5ml centrifuge tube, storing for one week at the temperature of minus 20 ℃, and then entering the step three;
step three, adding 400 mu l of absolute ethyl alcohol into the 1.5ml centrifuge tube containing the supernatant, and uniformly mixing by blowing and sucking with a suction head; pipetting 600. mu.l of the mixture, transferring the mixture to a nucleic acid purification column, tightly covering the tube cap, and centrifuging at 13,000rpm for 1 minute; discarding the filtrate, placing the nucleic acid purification column back into a 2ml centrifuge tube, transferring the remaining mixture to the nucleic acid purification column, tightly covering the tube cap, and centrifuging at 13,000rpm for 1 minute;
step four, washing and deproteinizing: discarding the filtrate, putting the nucleic acid purification column back to a 2ml centrifuge tube, adding 500. mu.l of washing solution 1, tightly covering the tube cover, and centrifuging at 13,000rpm for 1 minute;
step five, washing and desalting: discarding the filtrate, putting the nucleic acid purification column back to a 2ml centrifuge tube, adding 700. mu.l of washing solution 2, tightly covering the tube cover, and centrifuging at 13,000rpm for 1 minute;
step six, eluting RNA: discarding the filtrate, putting the nucleic acid purification column back into a 2ml centrifuge tube, and centrifuging at 14,000rpm for 1 minute; discarding the filtrate and centrifuge tube, placing the nucleic acid purification column into a 1.5ml of centrifuge tube without RNase, adding 50 μ l of RNase-Free Water into the center of the membrane of the purification column, tightly covering the tube cover, standing at room temperature for 1 minute, and centrifuging at 12,000rpm for 30 seconds; the column was discarded and the eluted RNA was used immediately for molecular biology experiments or stored at-80 ℃ until use.
The results of agarose gel electrophoresis of the extracted RNA are shown in FIG. 4.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents or improvements made within the spirit and principle of the present invention should be included in the scope of the present invention.

Claims (7)

1. A whole blood RNA rapid lysis solution is characterized in that every 1000ml volume is composed of the following components by mass/volume:
guanidine thiocyanate, 0.2M-4M;
ammonium thiocyanate, 0.2M-3M;
anhydrous sodium acetate, 0.01M-0.2M;
glacial acetic acid, 0.05M-0.3M;
0.1-2% (W/V) of sodium lauroyl sarcosinate;
sodium chloride, 0.02M-0.3M;
1% -15% (V/V) of glycerol;
water saturated phenol solution, 10% -75% (V/V);
the rest is DEPC treated water.
2. The application of the whole blood RNA rapid lysate in the whole blood column method for extracting RNA according to claim 1.
3. Use according to claim 3, characterized in that it comprises the following steps:
step one, whole blood lysis: adding 1ml of the rapid lysis solution into a 2ml centrifuge tube, adding 500 mu l of fresh whole blood or bone marrow, covering a tube cap, carrying out vortex oscillation for 30 seconds, and centrifuging at 13,000rpm for 10 minutes;
step two, passing the RNA-containing supernatant through a purification column: adding 400 mu l of absolute ethyl alcohol into a new 1.5ml centrifuge tube, sucking 700 mu l of the centrifugal supernatant obtained in the first step, transferring the centrifugal supernatant into the tube, and uniformly blowing and sucking the centrifugal supernatant by using a suction head; pipetting 600. mu.l of the mixture, transferring the mixture to a nucleic acid purification column, tightly covering the tube cap, and centrifuging at 13,000rpm for 1 minute; discarding the filtrate, placing the nucleic acid purification column back into a 2ml centrifuge tube, transferring the remaining mixture to the nucleic acid purification column, tightly covering the tube cap, and centrifuging at 13,000rpm for 1 minute;
step three, washing and deproteinizing: discarding the filtrate, putting the nucleic acid purification column back to a 2ml centrifuge tube, adding 500. mu.l of washing solution 1, tightly covering the tube cover, and centrifuging at 13,000rpm for 1 minute;
step four, washing and desalting: discarding the filtrate, putting the nucleic acid purification column back to a 2ml centrifuge tube, adding 700. mu.l of washing solution 2, tightly covering the tube cover, and centrifuging at 13,000rpm for 1 minute;
step five, eluting RNA: discarding the filtrate, putting the nucleic acid purification column back into a 2ml centrifuge tube, and centrifuging at 14,000rpm for 1 minute; discarding the filtrate and centrifuge tube, placing the nucleic acid purification column into a 1.5ml of centrifuge tube without RNase, adding 50 μ l of RNase-Free Water into the center of the membrane of the purification column, tightly covering the tube cover, standing at room temperature for 1 minute, and centrifuging at 12,000rpm for 30 seconds; the column was discarded and the eluted RNA was used immediately for molecular biology experiments or stored at-80 ℃ until use.
4. The use of claim 3, wherein the nucleic acid purification column is coated with SiO2Silica gel adsorption column of the material.
5. The use according to claim 3, wherein the lotion 1 is formulated with guanidinium thiocyanate 0.5M-4M, Tris-HCl (pH6.0-pH8.0)10mM-100mM, EDTA-2Na (pH8.0)10mM-50mM, and absolute ethanol 40% -60%.
6. The use according to claim 3, wherein the washing solution 2 is Tris-HCl (pH6.0-pH8.0)10mM-100mM, sodium chloride 20mM-300mM, and absolute ethanol 60% -80%.
7. The use according to claim 3, wherein the RNase-Free Water is 0.1% DEPC treated Water.
CN201910932018.8A 2019-09-29 2019-09-29 Whole blood RNA rapid lysis solution and application Pending CN110804609A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910932018.8A CN110804609A (en) 2019-09-29 2019-09-29 Whole blood RNA rapid lysis solution and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910932018.8A CN110804609A (en) 2019-09-29 2019-09-29 Whole blood RNA rapid lysis solution and application

Publications (1)

Publication Number Publication Date
CN110804609A true CN110804609A (en) 2020-02-18

Family

ID=69488017

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910932018.8A Pending CN110804609A (en) 2019-09-29 2019-09-29 Whole blood RNA rapid lysis solution and application

Country Status (1)

Country Link
CN (1) CN110804609A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112708618A (en) * 2020-12-30 2021-04-27 广州博江生物科技有限公司 Lysate for quickly lysing cells, viruses and bacteria to extract nucleic acid
CN112725334A (en) * 2021-02-23 2021-04-30 山东思科捷生物技术有限公司 Cell RNA rapid extraction kit and RNA extraction method
CN114908081A (en) * 2022-04-29 2022-08-16 杭州新景生物试剂开发有限公司 Nucleic acid extraction reagent, kit thereof and method for rapidly extracting, separating and purifying nucleic acid

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0614800A (en) * 1992-07-02 1994-01-25 Tosoh Corp Detection of human hepatitis virus c and a pair of primer therefor
CN1997740A (en) * 2004-04-16 2007-07-11 彼得·科姆钦斯基 Reagents and methods for isolating purified RNA
CN102876663A (en) * 2012-10-10 2013-01-16 北京百泰克生物技术有限公司 Reagent and method for rapidly extracting main RNA (ribonucleic acid) from liquid sample
US20140057247A1 (en) * 2012-08-24 2014-02-27 The Board Of Trustees Of The Leland Stanford Junior University Method of preparing rna from ribonuclease-rich sources
EP2557161B1 (en) * 2011-08-11 2015-05-20 AXAGARIUS GmbH & Co. KG Method for isolating RNA from full blood samples
CN105385680A (en) * 2015-12-24 2016-03-09 天津脉络生物科技有限公司 Reagent for simultaneous extraction of DNA and RNA, extraction method and application
CN106434633A (en) * 2016-10-25 2017-02-22 山东艾莱普生物科技有限公司 Quick osseous tissue RNA extraction kit
CN108070584A (en) * 2016-11-16 2018-05-25 江苏然科生物技术有限公司 The silica gel adsorption column extracts kit and method of a kind of blood plasma or free serum DNA and RNA
CN109385418A (en) * 2017-08-03 2019-02-26 杭州优思达生物技术有限公司 A kind of method extracted for virus in animal specimen/bacterial nucleic acid and reagent

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0614800A (en) * 1992-07-02 1994-01-25 Tosoh Corp Detection of human hepatitis virus c and a pair of primer therefor
CN1997740A (en) * 2004-04-16 2007-07-11 彼得·科姆钦斯基 Reagents and methods for isolating purified RNA
EP2557161B1 (en) * 2011-08-11 2015-05-20 AXAGARIUS GmbH & Co. KG Method for isolating RNA from full blood samples
US20140057247A1 (en) * 2012-08-24 2014-02-27 The Board Of Trustees Of The Leland Stanford Junior University Method of preparing rna from ribonuclease-rich sources
CN102876663A (en) * 2012-10-10 2013-01-16 北京百泰克生物技术有限公司 Reagent and method for rapidly extracting main RNA (ribonucleic acid) from liquid sample
CN105385680A (en) * 2015-12-24 2016-03-09 天津脉络生物科技有限公司 Reagent for simultaneous extraction of DNA and RNA, extraction method and application
CN106434633A (en) * 2016-10-25 2017-02-22 山东艾莱普生物科技有限公司 Quick osseous tissue RNA extraction kit
CN108070584A (en) * 2016-11-16 2018-05-25 江苏然科生物技术有限公司 The silica gel adsorption column extracts kit and method of a kind of blood plasma or free serum DNA and RNA
CN109385418A (en) * 2017-08-03 2019-02-26 杭州优思达生物技术有限公司 A kind of method extracted for virus in animal specimen/bacterial nucleic acid and reagent

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CATHERINE BONAÏTI等: "Novel extraction strategy of ribosomal RNA and genomic DNA from cheese for PCR-based investigations", 《INT J FOOD MICROBIOL》 *
杨利丽等: "一种改进的异硫氰酸胍法结合硅胶膜离心吸附柱提取孕妇外周血微量胎儿RNA的方法", 《中国生物化学与分子生物学报》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112708618A (en) * 2020-12-30 2021-04-27 广州博江生物科技有限公司 Lysate for quickly lysing cells, viruses and bacteria to extract nucleic acid
CN112725334A (en) * 2021-02-23 2021-04-30 山东思科捷生物技术有限公司 Cell RNA rapid extraction kit and RNA extraction method
CN114908081A (en) * 2022-04-29 2022-08-16 杭州新景生物试剂开发有限公司 Nucleic acid extraction reagent, kit thereof and method for rapidly extracting, separating and purifying nucleic acid
CN114908081B (en) * 2022-04-29 2024-06-18 杭州新景生物试剂开发有限公司 Nucleic acid extraction reagent, kit thereof and method for rapidly extracting, separating and purifying nucleic acid

Similar Documents

Publication Publication Date Title
CN110804609A (en) Whole blood RNA rapid lysis solution and application
US8048681B2 (en) Methods for nucleic acid isolation and instruments for nucleic acid isolation
CN111808844A (en) Kit for simultaneously extracting DNA and RNA and use method thereof
US20080176320A1 (en) Selective Lysis of Sperm Cells
US8017332B2 (en) Magnetic method for recovering nucleic acid from a mixed cell suspension
CN103739664B (en) Methods for separating and identifying DNA (deoxyribonucleic acid) binding protein through DNA co-immunoprecipitation
CN110257368A (en) The method and system of free nucleic acid is separated from the sample containing free nucleic acid
CN111996190A (en) Whole blood genome DNA extraction kit
JP2018198599A (en) One step method for purifying nucleic acid
CN102154264A (en) Method for rapidly extracting total ribonucleic acid from blood
CN112941067A (en) Lysis binding solution for whole blood nucleic acid extraction and kit and application thereof
CN114908081B (en) Nucleic acid extraction reagent, kit thereof and method for rapidly extracting, separating and purifying nucleic acid
CN110699429B (en) Urine DNA extraction and preservation solution, urine preservation tube, extraction kit and extraction method
CN112080492A (en) High-yield free DNA and RNA co-extraction kit and use method thereof
CN114350650A (en) Kit for extracting RNA from blood without DNA residue and method for extracting nucleic acid
CN108866042B (en) Extraction method of trace RNA
RU2808832C1 (en) Method of isolating viral ribonucleic acid from cerebrospinal fluid for molecular biological research
CN112458082A (en) Rapid one-step nucleic acid extraction reagent and preparation method thereof
CN109182328B (en) Mitochondrial DNA extraction kit and method
DE19607202A1 (en) Separation of RNA and DNA from cells by treatment with lytic solution
CN109355286A (en) A method of exempting from pre-treatment automation and extracts large volume whole blood DNA
CN114107449B (en) Single-cell in-situ qPCR method
CN117625740B (en) Method for rapidly extracting DNA suitable for high-throughput sequencing from Trizol sample
CN115201356B (en) High-flux unbiased endogenous liquid-liquid phase separation protein screening method
US20240002833A1 (en) Method for isolating nucleic acid using binding buffer including compound having low or intermediate dielectric constant

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination